Supriya Lifescience Ltd Share Price Today - Supriya Lifescience Ltd Stock Price Live NSE/BSE

Supriya Lifescience Ltd

NSE: SUPRIYA BSE: 543434

₹706.70

(0.81%)

Wed, 20 May 2026, 04:17 am

MTF 5xInvest in Supriya Lifescience Ltd with 5x Leverage Buy with MTF

Market Cap56.97B

PE Ratio30.70

Dividend0.14

Health Technology

Pharmaceuticals: Major

24.5K

Supriya Lifescience Share Price Live Chart

1 Day

(0.81%)

No Result Found

Summary

Market Cap
5816.89
Net Profit
187.96
P/B
5.92
Sector P/E
44.55
P/E
31.42
EV/EBITDA
21.53
Debt/Equity (Industry)
0.24
Interest Cover (Industry)
9.79
ROCE (Industry)
14.05
RONW (Industry)
13.18
ROE
20.74
ROCE
27.43
Debt/Equity
0.01
EPS (TTM)
23.06
Dividend Yield
0.14
Book Value
134.41
Interest Cover
138.28

Analysis

No Result Found

Financials

Ratios

Shareholders	MAR 2026	DEC 2025	SEPT 2025	JUN 2025	MAR 2025
Promoters	68.30	68.30	68.30	68.30	68.30
FII	5.16	5.20	5.46	6.78	7.19
DII	5.70	5.01	5.22	4.86	4.26
Public	20.84	21.50	21.02	20.06	20.26
Government	0	0	0	0	0

Technical Analysis

RSI

65.11

MACD

17.78

50 DMA

638.50

200 DMA

693.27

Support and Resistance

Type	R3	R2	R1	PP	S1	S2	S3
Classic	955.77	808.27	751.58	660.77	604.08	513.27	365.77
Fibonacci	808.27	751.92	717.11	660.77	604.42	569.61	513.27
Camarilla	735.46	721.94	708.42	660.77	681.38	667.86	654.34

Pivots Level: Classic

+295

955.77

+147.50

808.27

+90.82

751.58

660.77

Pivot Point

LTP: 728.40

-56.68

604.08

-147.50

513.27

-295

365.77

Moving Average

SMAEMA

Period

Value

10-EMA
700.31
20-EMA
686.88
30-EMA
676.14
50-EMA
667.27
100-EMA
671.77
200-EMA
678.25

Announcement Date	Purpose	Action	Ex Date
09 Feb 2026	board-meetings	Quarterly Results
02 Sept 2025	agm
05 Aug 2025	dividend	Final Dividend - Rs. - 1	05 Sept 2025
04 Aug 2025	dividend	Dividend - Re 1 Per Share	05 Sept 2025
27 May 2025	dividend	₹1.00 Dividend /Share	05 Sept 2025
13 Sept 2024	agm
20 Aug 2024	dividend	Annual General Meeting/Dividend - Rs 0.80 Per Share	21 Sept 2024
28 May 2024	dividend	₹0.80 Dividend /Share	21 Sept 2024
04 Sept 2023	agm
15 Aug 2023	dividend	Annual General Meeting/Dividend - Re 0.60 Per Share	16 Sept 2023

Supriya Lifescience Ltd

Divis Laboratories Ltd

Cipla Ltd

Dr Reddys Laboratories Ltd

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd

Supriya Lifescience Ltd About

Supriya Lifesciences is primarily engaged in manufacturing of Bulk Drugs and Pharmaceutical Chemicals.

Industry

Pharmaceuticals - Indian - Bulk Drugs & Formln

Founded

2008

Headquarters

CEO

Satish Waman Wagh

Employees

Contact

Website

http://www.supriyalifescience.com

cs@supriyalifescience.com

Phone

91-22-40332727

Location

207/208 Udyog Bhavan, Sonawala Road Goregaon (East), Mumbai, Maharashtra, 400063

Year	History
2018	CEP (Certificate of Sustainability) was granted for Brompheniramine Maleate, Mepyramine Maleate and Ketamine Hydrochloride.
2020	Third time USFDA approval was granted.
2021	CEP (Certificate of Suitability) was granted for Pentoxifylline, Esketamine Hydrochloride and Salbutamol Sulphate. NMPA approval was granted. Health Canada approval was granted.
2022	Supriya Lifescience Limited signed a captive solar project agreement with Enrich Energy Pvt. Ltd.
2024	Supriya Lifescience Ltd inaugurated a state-of-the-art Module E production block at Lote Parshuram, Maharashtra. Supriya Lifescience inaugurated a Rs 125 crore API production block at Lote Parshuram site.

Client Name	Deal Type	Order Side	QTY	Avg Price	Date
GRAVITON RESEARCH CAPITAL LLP	bulk	Sell	585068	785.02	22 Nov 2024
GRAVITON RESEARCH CAPITAL LLP	bulk	Buy	585068	784.79	22 Nov 2024
GRAVITON RESEARCH CAPITAL LLP	bulk	Buy	658285	488.59	12 Aug 2024
GRAVITON RESEARCH CAPITAL LLP	bulk	Sell	658285	488.61	12 Aug 2024
GRAVITON RESEARCH CAPITAL LLP	bulk	Sell	627793	342.32	08 Feb 2024
GRAVITON RESEARCH CAPITAL LLP	bulk	Buy	627793	342.21	08 Feb 2024
GRAVITON RESEARCH CAPITAL LLP	bulk	Buy	456665	312.26	26 Dec 2023
GRAVITON RESEARCH CAPITAL LLP	bulk	Sell	456665	312.4	26 Dec 2023
GRAVITON RESEARCH CAPITAL LLP	bulk	Sell	403147	248.48	12 May 2023
GRAVITON RESEARCH CAPITAL LLP	bulk	Buy	403147	248.38	12 May 2023

Supriya Lifescience Ltd News

Supriya Lifescience Gets VAI Rating from USFDA

Supriya Lifescience Limited successfully completes USFDA inspection at its manufacturing facility with VAI rating, encountering only one minor issue during the regulatory review process.

23 Apr 2026

companies

Supriya Lifescience Gets VAI Rating from USFDA

Supriya Lifescience Limited successfully completes USFDA inspection at its manufacturing facility with VAI rating, encountering only one minor issue during the regulatory review process.

22 Apr 2026

companies

Supriya Lifescience Gets VAI Rating from USFDA

Supriya Lifescience Limited successfully completes USFDA inspection at its manufacturing facility with VAI rating, encountering only one minor issue during the regulatory review process.

22 Apr 2026

companies

Madhu Kela Increases Supriya Lifescience Stake by 0.4%

Prominent investor Madhu Kela has increased his shareholding in Supriya Lifescience by 0.4% during the fourth quarter, reflecting continued confidence in the pharmaceutical company's prospects.

17 Apr 2026

companies

Supriya Lifescience Completes Director Appointments

Supriya Lifescience Limited successfully completed postal ballot process for appointing three independent directors with overwhelming shareholder support exceeding 99% across all resolutions.

12 Apr 2026

companies

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

Version -5.76

Stocks:

All A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Explore

Calculators

Popular Calculators

Group Stocks

Others:

NSE BSE CDSL NSDL SEBI MCX MSEI NCDEX NSE IFSC INDIA INX Account Closure Form DP Investor Charter Broker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800